Lexology January 28, 2025
Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle drug pricing reforms over the next four years. However, Biden-era policies are likely to limit a comprehensive overhaul of existing reforms in the near term.
Former President Biden Signs the Inflation Reduction Act into Law
In 2022, President Biden signed the Inflation Reduction Act (IRA) into law, beckoning the implementation of sprawling drug pricing reforms, including formalization of the Medicare Drug Price Negotiation Program and the establishment of inflation rebates for certain drug price increases, among other reforms related to Medicare Part B and D drug costs.
Of particular import, the establishment of the Medicare Drug Price Negotiation Program granted the Centers for...
Today's Sponsors
Today's Sponsor